Navigation Links
Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
Date:5/21/2008

t Sunesis' preclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials and manufacturing of voreloxin and risks related to Sunesis' need for additional funding. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' annual report on Form 10-K for the year ended December 31, 2007 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
2. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
3. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
4. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
5. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
10. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
11. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
(Date:8/29/2014)... , Aug. 29, 2014   Mast Therapeutics, ... company, announced today that Santosh Vetticaden, Chief Medical ... the Company, for personal reasons, in mid-September.  ... Officer of Aires Pharmaceuticals, which Mast acquired earlier ... as the Company,s interim Chief Medical Officer.  Dr. ...
(Date:8/29/2014)... -- Research and Markets has announced the ... & Pipeline Insight 2014" report to their offering. ... and eradicate the prevalence of cancer have achieved limited ... low specificity, safety and large number of side effects, ... solution. It has been discovered that peptides can be ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2
... PLEASANTON, Calif., Feb. 14, 2012  Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... Leerink Swann 2012 Global Healthcare Conference on Thursday, February ... Investor Relations and Business Development, will provide an update ...
... Feb. 14, 2012 Glenveigh Medical  announced today that ... its request for orphan drug designation for a potential ... compound, digoxin immune fab (ovine) , is an ... toxicity. Glenveigh, a nationally renowned life science company, has ...
Cached Medicine Technology:Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and Eclampsia 2
(Date:8/30/2014)... 2014 Bringing forth the great opportunities, ... announces the Labor Day discount on all SEO services. ... the complete services related to internet marketing. Their dedicated ... and others do have a deep understanding for their ... their work and since the inception, they have worked ...
(Date:8/30/2014)... 2014 "I had a handicapped friend who ... said an inventor from Wetumpka, Ala. "In order to help ... the shore, I came up with a way for her ... a prototype for the patent-pending Deezers to allow crutches to ... to use crutches, walkers, or canes at the beach. The ...
(Date:8/30/2014)... Bethesda, MD (PRWEB) August 30, 2014 In ... and increasingly difficult to get. Snoring and sleep apnea (a ... stops) robs people and their bed partners of the rest ... to 45% of the population snores and 20 million people ... only 10% have been diagnosed and treated; and of those ...
(Date:8/30/2014)... One of the most recent dietary trends to ... Originally meant for sufferers of gluten intolerance and celiac disease, ... are looking to get healthier by simply consuming foods which ... of information erroneous, it also exposes those same consumers to ... drastic change in their food consumption habits. , ...
(Date:8/30/2014)... 2014 The new review published by Daily ... by Karen Brimeyer, who wanted to make her guide accessible ... guide is now easy to find in the form of ... guide, the author of the new method shares all her ... Gossip writes in its review that the leaky gut syndrome ...
Breaking Medicine News(10 mins):Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2
... Oct. 8 Health by Design of San Antonio, TX, ... individuals, has recently appointed Omar Rodriguez as Executive Vice President, ... in the health care arena, Rodriguez assumes a newly created ... its unique approach to medical care. His first area of ...
... Major League Baseball players have just learned they,re in the running ... list of 10 players, one of whom will go on to ... Center in January. The finalists for the 45th annual Hutch Award ... Braves Torii Hunter, Los Angeles Angels of Anaheim Mark ...
... In reports from Australia and U.S., most patients recovering, ... 8 (HealthDay News) -- Potentially foreshadowing the U.S. experience ... authorities who have just gone through their flu season ... a result of H1N1 swine flu infections. , Because ...
... and where DNA fits into cells , THURSDAY, Oct. 8 ... has been deciphered by U.S. researchers, an achievement that improves ... DNA can be packed into each human cell. , The ... to conduct genomewide analysis of the proximity of individual genes. ...
... announces that a new market research report is ... Adds Germany Wound Care Management Market Analysis and ... http://www.reportlinker.com/p0151443/Reportlinker-Adds-Germany-Wound-Care-Management-Market-Analysis-and-Forecasts-to-2015.html , Summary ... and Forecasts to 2015 report provides key data, ...
... individuals profiled in the new PBS documentary This Emotional ... at the Paley Center for Media in New York for ... life moments can shape a lifetime pursuit of happiness. ... psychologist and host of the series, which is a co-production ...
Cached Medicine News:Health News:Health Care Industry Leader Joins Health by Design Executive Team 2Health News:Ten Finalists Chosen for Hutch Award(R) 2Health News:Swine Flu May Bring Surge in Hospitalizations 2Health News:Swine Flu May Bring Surge in Hospitalizations 3Health News:New Technology Shows Human Genome in 3-D 2Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 14Health News:Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 2Health News:Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 3Health News:Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 4Health News:Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 5
Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
... on the market leading optical performance of ... been optimized for even better views of ... including a new XHL Xenon Halogen Technology ... and clear, high resolution images of the ...
Medicine Products: